Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Travé G[au]:

Search results

Items: 1 to 50 of 72

1.

A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.

Celegato M, Messa L, Goracci L, Mercorelli B, Bertagnin C, Spyrakis F, Suarez I, Cousido-Siah A, Travé G, Banks L, Cruciani G, Palù G, Loregian A.

Cancer Lett. 2020 Feb 1;470:115-125. doi: 10.1016/j.canlet.2019.10.046. Epub 2019 Nov 3.

PMID:
31693922
2.

High-Throughput Production of a New Library of Human Single and Tandem PDZ Domains Allows Quantitative PDZ-Peptide Interaction Screening Through High-Throughput Holdup Assay.

Duhoo Y, Girault V, Turchetto J, Ramond L, Durbesson F, Fourquet P, Nominé Y, Cardoso V, Sequeira AF, Brás JLA, Fontes CMGA, Travé G, Wolff N, Vincentelli R.

Methods Mol Biol. 2019;2025:439-476. doi: 10.1007/978-1-4939-9624-7_21.

PMID:
31267466
3.

Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation.

Gógl G, Biri-Kovács B, Durbesson F, Jane P, Nomine Y, Kostmann C, Bilics V, Simon M, Reményi A, Vincentelli R, Trave G, Nyitray L.

J Mol Biol. 2019 Mar 15;431(6):1234-1249. doi: 10.1016/j.jmb.2019.01.038. Epub 2019 Feb 3.

PMID:
30726710
4.

One-step affinity purification of fusion proteins with optimal monodispersity and biological activity: application to aggregation-prone HPV E6 proteins.

Bonhoure A, Demenge A, Kostmann C, San José L, De la Cal E, Armisen P, Nominé Y, Travé G.

Microb Cell Fact. 2018 Dec 1;17(1):191. doi: 10.1186/s12934-018-1039-z.

5.

Human papillomavirus type 16 antagonizes IRF6 regulation of IL-1β.

Ainouze M, Rochefort P, Parroche P, Roblot G, Tout I, Briat F, Zannetti C, Marotel M, Goutagny N, Auron P, Traverse-Glehen A, Lunel-Potencier A, Golfier F, Masson M, Robitaille A, Tommasino M, Carreira C, Walzer T, Henry T, Zanier K, Trave G, Hasan UA.

PLoS Pathog. 2018 Aug 8;14(8):e1007158. doi: 10.1371/journal.ppat.1007158. eCollection 2018 Aug.

6.

Structural Insights in Multifunctional Papillomavirus Oncoproteins.

Suarez I, Trave G.

Viruses. 2018 Jan 15;10(1). pii: E37. doi: 10.3390/v10010037. Review.

7.

Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.

Poirson J, Biquand E, Straub ML, Cassonnet P, Nominé Y, Jones L, van der Werf S, Travé G, Zanier K, Jacob Y, Demeret C, Masson M.

FEBS J. 2017 Oct;284(19):3171-3201. doi: 10.1111/febs.14193. Epub 2017 Aug 29.

8.

HPV-mediated inactivation of tumor suppressor p53.

Travé G, Zanier K.

Cell Cycle. 2016 Sep;15(17):2231-2. doi: 10.1080/15384101.2016.1191257. Epub 2016 May 31. No abstract available.

9.

Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.

Martinez-Zapien D, Ruiz FX, Poirson J, Mitschler A, Ramirez J, Forster A, Cousido-Siah A, Masson M, Vande Pol S, Podjarny A, Travé G, Zanier K.

Nature. 2016 Jan 28;529(7587):541-5. doi: 10.1038/nature16481. Epub 2016 Jan 20.

10.

Antibody Binding Selectivity: Alternative Sets of Antigen Residues Entail High-Affinity Recognition.

Nominé Y, Choulier L, Travé G, Vernet T, Altschuh D.

PLoS One. 2015 Dec 2;10(12):e0143374. doi: 10.1371/journal.pone.0143374. eCollection 2015.

11.

Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells.

Bonetta AC, Mailly L, Robinet E, Travé G, Masson M, Deryckere F.

Biochem Biophys Res Commun. 2015 Oct 2;465(4):658-64. doi: 10.1016/j.bbrc.2015.07.144. Epub 2015 Aug 1.

PMID:
26241675
12.

Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.

Stutz C, Reinz E, Honegger A, Bulkescher J, Schweizer J, Zanier K, Travé G, Lohrey C, Hoppe-Seyler K, Hoppe-Seyler F.

PLoS One. 2015 Jul 7;10(7):e0132339. doi: 10.1371/journal.pone.0132339. eCollection 2015.

13.

Quantifying domain-ligand affinities and specificities by high-throughput holdup assay.

Vincentelli R, Luck K, Poirson J, Polanowska J, Abdat J, Blémont M, Turchetto J, Iv F, Ricquier K, Straub ML, Forster A, Cassonnet P, Borg JP, Jacob Y, Masson M, Nominé Y, Reboul J, Wolff N, Charbonnier S, Travé G.

Nat Methods. 2015 Aug;12(8):787-93. doi: 10.1038/nmeth.3438. Epub 2015 Jun 8.

14.

Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.

Ramirez J, Poirson J, Foltz C, Chebaro Y, Schrapp M, Meyer A, Bonetta A, Forster A, Jacob Y, Masson M, Deryckère F, Travé G.

Angew Chem Int Ed Engl. 2015 Jun 26;54(27):7958-62. doi: 10.1002/anie.201502646. Epub 2015 May 27.

15.

Spot peptide arrays and SPR measurements: throughput and quantification in antibody selectivity studies.

Vernet T, Choulier L, Nominé Y, Bellard L, Baltzinger M, Travé G, Altschuh D.

J Mol Recognit. 2015 Oct;28(10):635-44. doi: 10.1002/jmr.2477. Epub 2015 May 11.

PMID:
25960426
16.

Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.

Karlsson OA, Ramirez J, Öberg D, Malmqvist T, Engström Å, Friberg M, Chi CN, Widersten M, Travé G, Nilsson MT, Jemth P.

Sci Rep. 2015 Mar 23;5:9382. doi: 10.1038/srep09382.

17.

Disorder-to-order transition of MAGI-1 PDZ1 C-terminal extension upon peptide binding: thermodynamic and dynamic insights.

Ramírez J, Recht R, Charbonnier S, Ennifar E, Atkinson RA, Travé G, Nominé Y, Kieffer B.

Biochemistry. 2015 Feb 17;54(6):1327-37. doi: 10.1021/bi500845j. Epub 2015 Feb 3.

PMID:
25590897
18.

The E6AP binding pocket of the HPV16 E6 oncoprotein provides a docking site for a small inhibitory peptide unrelated to E6AP, indicating druggability of E6.

Zanier K, Stutz C, Kintscher S, Reinz E, Sehr P, Bulkescher J, Hoppe-Seyler K, Travé G, Hoppe-Seyler F.

PLoS One. 2014 Nov 10;9(11):e112514. doi: 10.1371/journal.pone.0112514. eCollection 2014.

19.

An RNA Aptamer Targets the PDZ-Binding Motif of the HPV16 E6 Oncoprotein.

Belyaeva TA, Nicol C, Cesur O, Travé G, Blair GE, Stonehouse NJ.

Cancers (Basel). 2014 Jul 24;6(3):1553-69. doi: 10.3390/cancers6031553.

20.

Effect of serine phosphorylation and Ser25 phospho-mimicking mutations on nuclear localisation and ligand interactions of annexin A2.

Grindheim AK, Hollås H, Ramirez J, Saraste J, Travé G, Vedeler A.

J Mol Biol. 2014 Jun 26;426(13):2486-99. doi: 10.1016/j.jmb.2014.04.019. Epub 2014 Apr 26.

PMID:
24780253
21.

Production and characterization of a retinoic acid receptor RARγ construction encompassing the DNA binding domain and the disordered N-terminal proline rich domain.

Martinez-Zapien D, Delsuc MA, Travé G, Lutzing R, Rochette-Egly C, Kieffer B.

Protein Expr Purif. 2014 Mar;95:113-20. doi: 10.1016/j.pep.2013.12.001. Epub 2013 Dec 13.

PMID:
24333369
22.

Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.

Zanier K, Charbonnier S, Sidi AO, McEwen AG, Ferrario MG, Poussin-Courmontagne P, Cura V, Brimer N, Babah KO, Ansari T, Muller I, Stote RH, Cavarelli J, Vande Pol S, Travé G.

Science. 2013 Feb 8;339(6120):694-8. doi: 10.1126/science.1229934.

23.

Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase.

Neveu G, Cassonnet P, Vidalain PO, Rolloy C, Mendoza J, Jones L, Tangy F, Muller M, Demeret C, Tafforeau L, Lotteau V, Rabourdin-Combe C, Travé G, Dricot A, Hill DE, Vidal M, Favre M, Jacob Y.

Methods. 2012 Dec;58(4):349-59. doi: 10.1016/j.ymeth.2012.07.029. Epub 2012 Aug 8.

24.

The emerging contribution of sequence context to the specificity of protein interactions mediated by PDZ domains.

Luck K, Charbonnier S, Travé G.

FEBS Lett. 2012 Aug 14;586(17):2648-61. doi: 10.1016/j.febslet.2012.03.056. Epub 2012 Apr 4. Review.

25.

Thermal stability of chicken brain α-spectrin repeat 17: a spectroscopic study.

Brenner AK, Kieffer B, Travé G, Frøystein NA, Raae AJ.

J Biomol NMR. 2012 Jun;53(2):71-83. doi: 10.1007/s10858-012-9620-y. Epub 2012 May 9.

PMID:
22569754
26.

Solution structure analysis of the HPV16 E6 oncoprotein reveals a self-association mechanism required for E6-mediated degradation of p53.

Zanier K, ould M'hamed ould Sidi A, Boulade-Ladame C, Rybin V, Chappelle A, Atkinson A, Kieffer B, Travé G.

Structure. 2012 Apr 4;20(4):604-17. doi: 10.1016/j.str.2012.02.001. Epub 2012 Apr 3.

27.

Putting into practice domain-linear motif interaction predictions for exploration of protein networks.

Luck K, Fournane S, Kieffer B, Masson M, Nominé Y, Travé G.

PLoS One. 2011;6(11):e25376. doi: 10.1371/journal.pone.0025376. Epub 2011 Nov 1.

28.

Proteasomal degradation of p53 by human papillomavirus E6 oncoprotein relies on the structural integrity of p53 core domain.

Bernard X, Robinson P, Nominé Y, Masson M, Charbonnier S, Ramirez-Ramos JR, Deryckere F, Travé G, Orfanoudakis G.

PLoS One. 2011;6(10):e25981. doi: 10.1371/journal.pone.0025981. Epub 2011 Oct 27.

29.

PDZ-peptide complexes: as exciting as ever.

Trave G.

Structure. 2011 Oct 12;19(10):1350-1. doi: 10.1016/j.str.2011.09.008.

30.

Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Sidi AO, Babah KO, Brimer N, Nominé Y, Romier C, Kieffer B, Pol SV, Travé G, Zanier K.

Protein Expr Purif. 2011 Nov;80(1):8-16. doi: 10.1016/j.pep.2011.06.013. Epub 2011 Jul 14.

31.

Phage display can select over-hydrophobic sequences that may impair prediction of natural domain-peptide interactions.

Luck K, Travé G.

Bioinformatics. 2011 Apr 1;27(7):899-902. doi: 10.1093/bioinformatics/btr060. Epub 2011 Feb 7.

PMID:
21300698
32.

The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6.

Charbonnier S, Nominé Y, Ramírez J, Luck K, Chapelle A, Stote RH, Travé G, Kieffer B, Atkinson RA.

J Mol Biol. 2011 Mar 11;406(5):745-63. doi: 10.1016/j.jmb.2011.01.015. Epub 2011 Jan 13.

PMID:
21238461
33.

How viruses hijack cell regulation.

Davey NE, Travé G, Gibson TJ.

Trends Biochem Sci. 2011 Mar;36(3):159-69. doi: 10.1016/j.tibs.2010.10.002. Epub 2010 Dec 9.

PMID:
21146412
34.

Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity.

Fu L, Van Doorslaer K, Chen Z, Ristriani T, Masson M, Travé G, Burk RD.

PLoS One. 2010 Sep 17;5(9). pii: e12816. doi: 10.1371/journal.pone.0012816.

35.

Surface plasmon resonance analysis of the binding of high-risk mucosal HPV E6 oncoproteins to the PDZ1 domain of the tight junction protein MAGI-1.

Fournane S, Charbonnier S, Chapelle A, Kieffer B, Orfanoudakis G, Travé G, Masson M, Nominé Y.

J Mol Recognit. 2011 Jul-Aug;24(4):511-23. doi: 10.1002/jmr.1056. Epub 2010 Sep 14.

PMID:
20842623
36.

Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein.

Boumlic A, Nominé Y, Charbonnier S, Dalagiorgou G, Vassilaki N, Kieffer B, Travé G, Mavromara P, Orfanoudakis G.

FEBS J. 2010 Feb;277(3):774-89. doi: 10.1111/j.1742-4658.2009.07527.x. Epub 2010 Jan 7.

37.

ELM: the status of the 2010 eukaryotic linear motif resource.

Gould CM, Diella F, Via A, Puntervoll P, Gemünd C, Chabanis-Davidson S, Michael S, Sayadi A, Bryne JC, Chica C, Seiler M, Davey NE, Haslam N, Weatheritt RJ, Budd A, Hughes T, Pas J, Rychlewski L, Travé G, Aasland R, Helmer-Citterich M, Linding R, Gibson TJ.

Nucleic Acids Res. 2010 Jan;38(Database issue):D167-80. doi: 10.1093/nar/gkp1016. Epub 2009 Nov 17.

38.

E6 proteins from diverse papillomaviruses self-associate both in vitro and in vivo.

Zanier K, Ruhlmann C, Melin F, Masson M, Ould M'hamed Ould Sidi A, Bernard X, Fischer B, Brino L, Ristriani T, Rybin V, Baltzinger M, Vande Pol S, Hellwig P, Schultz P, Travé G.

J Mol Biol. 2010 Feb 12;396(1):90-104. doi: 10.1016/j.jmb.2009.11.022. Epub 2009 Nov 13.

39.

Identification of unusual E6 and E7 proteins within avian papillomaviruses: cellular localization, biophysical characterization, and phylogenetic analysis.

Van Doorslaer K, Sidi AO, Zanier K, Rybin V, Deryckère F, Rector A, Burk RD, Lienau EK, van Ranst M, Travé G.

J Virol. 2009 Sep;83(17):8759-70. doi: 10.1128/JVI.01777-08. Epub 2009 Jun 24.

40.

A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.

Ristriani T, Fournane S, Orfanoudakis G, Travé G, Masson M.

Oncogene. 2009 Feb 5;28(5):762-72. doi: 10.1038/onc.2008.422. Epub 2008 Nov 17.

PMID:
19015633
41.

Understanding eukaryotic linear motifs and their role in cell signaling and regulation.

Diella F, Haslam N, Chica C, Budd A, Michael S, Brown NP, Trave G, Gibson TJ.

Front Biosci. 2008 May 1;13:6580-603. Review.

PMID:
18508681
42.

Defining the minimal interacting regions of the tight junction protein MAGI-1 and HPV16 E6 oncoprotein for solution structure studies.

Charbonnier S, Stier G, Orfanoudakis G, Kieffer B, Atkinson RA, Travé G.

Protein Expr Purif. 2008 Jul;60(1):64-73. doi: 10.1016/j.pep.2008.03.022. Epub 2008 Mar 31.

PMID:
18467125
43.

Discovery of candidate KEN-box motifs using cell cycle keyword enrichment combined with native disorder prediction and motif conservation.

Michael S, Travé G, Ramu C, Chica C, Gibson TJ.

Bioinformatics. 2008 Feb 15;24(4):453-7. doi: 10.1093/bioinformatics/btm624. Epub 2008 Jan 9.

PMID:
18184688
44.

The mRNA-binding site of annexin A2 resides in helices C-D of its domain IV.

Aukrust I, Hollås H, Strand E, Evensen L, Travé G, Flatmark T, Vedeler A.

J Mol Biol. 2007 May 18;368(5):1367-78. Epub 2007 Mar 7.

PMID:
17395201
45.

Formation of well-defined soluble aggregates upon fusion to MBP is a generic property of E6 proteins from various human papillomavirus species.

Zanier K, Nominé Y, Charbonnier S, Ruhlmann C, Schultz P, Schweizer J, Travé G.

Protein Expr Purif. 2007 Jan;51(1):59-70. Epub 2006 Sep 9.

PMID:
17055740
46.

NMR in the SPINE Structural Proteomics project.

Ab E, Atkinson AR, Banci L, Bertini I, Ciofi-Baffoni S, Brunner K, Diercks T, Dötsch V, Engelke F, Folkers GE, Griesinger C, Gronwald W, Günther U, Habeck M, de Jong RN, Kalbitzer HR, Kieffer B, Leeflang BR, Loss S, Luchinat C, Marquardsen T, Moskau D, Neidig KP, Nilges M, Piccioli M, Pierattelli R, Rieping W, Schippmann T, Schwalbe H, Travé G, Trenner J, Wöhnert J, Zweckstetter M, Kaptein R.

Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1150-61. Epub 2006 Sep 19. Review.

PMID:
17001092
47.

Engineering, biophysical characterisation and binding properties of a soluble mutant form of annexin A2 domain IV that adopts a partially folded conformation.

Aukrust I, Evensen L, Hollås H, Berven F, Atkinson RA, Travé G, Flatmark T, Vedeler A.

J Mol Biol. 2006 Oct 20;363(2):469-81. Epub 2006 Aug 22.

PMID:
16963080
48.

Capturing protein-protein complexes at equilibrium: the holdup comparative chromatographic retention assay.

Charbonnier S, Zanier K, Masson M, Travé G.

Protein Expr Purif. 2006 Nov;50(1):89-101. Epub 2006 Jun 27.

PMID:
16884919
49.

13C, 15N and 1H resonance assignment of the PDZ1 domain of MAGI-1 using QUASI.

Charbonnier S, Coutouly MA, Kieffer B, Travé G, Atkinson RA.

J Biomol NMR. 2006;36 Suppl 1:33. No abstract available.

PMID:
16636753
50.

Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

Nominé Y, Masson M, Charbonnier S, Zanier K, Ristriani T, Deryckère F, Sibler AP, Desplancq D, Atkinson RA, Weiss E, Orfanoudakis G, Kieffer B, Travé G.

Mol Cell. 2006 Mar 3;21(5):665-78.

Supplemental Content

Support Center